PATHOGENESIS OF XANTHOMATA

被引：56

作者：

WALTON, KW ^{[1
]}

THOMAS, C ^{[1
]}

DUNKERLEY, DJ ^{[1
]}

机构：

[1] UNIV BIRMINGHAM, DEPT EXPTL PATHOL, BIRMINGHAM, ENGLAND

来源：

关键词：

D O I：

10.1002/path.1711090402

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：271 / +

页数：1

共 50 条

[1] PHOSPHOLIPIDS IN ATHEROSCLEROSIS - MODIFICATION OF CHOLESTEROL GRANULOMA BY PHOSPHOLIPID
ADAMS, CWM
BAYLISS, OB
WEBSTER, MW
IBRAHIM, MZM
[J]. JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1963, 86 (02): : 431 - &
[2] AMENTA J. S., 1960, YALE JOUR BIOL AND MED, V33, P112
[3] FORMATION OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-BETA-LIPOPROTEIN COMPLEXES - CHEMICAL AND FIBRINOLYTIC PROPERTIES
ANDERSON, AJ
[J]. BIOCHEMICAL JOURNAL, 1963, 88 (03) : 460 - &
[4] Anitschkow N, 1913, BEITR PATHOL ANAT AL, V56, P379
[5] Experimental analysis on the clogging of subcutanian connective tissue from cholesterol fats
Anitschkow, N
[J]. ARCHIV FUR DERMATOLOGIE UND SYPHILIS, 1914, 120 : 627 - 674
[6] Anitschkow N., 1933, ARTERIOSCLEROSIS
[7] BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
[8] CORNWELL DG, 1961, J LIPID RES, V2, P110
[9] CLINICAL TRIAL OF METHYL CLOFENAPATE (A DERIVATIVE OF CLOFIBRATE) IN PATIENTS WITH ESSENTIAL HYPERLIPIDEMIAS - WITH SPECIAL REFERENCE TO TYPE II (PRIMARY) HYPERLIPIDEMIA
CRAIG, GM
WALTON, KW
[J]. ATHEROSCLEROSIS, 1972, 15 (02) : 189 - &
[10] CROCKSON R A., 1962, JOUR MED LAB TECHNOL, V19, P243